Health Canada Approved
Majik Minds Dealer's License Granted by Health Canada
It brings me great pleasure to announce that Majik Minds Inc has received its Dealer's License for psilocybin cultivation, production and formulation located at the Sooke Business Park just outside of Victoria. Growing and cultivation will commence in September and shortly after, a safety trial under direction of Dr JP Lim will commence. This will allow Majik to sell its formulations to the clinic division already in operation and in a cash flow positive state.
It is through this disciplined approach of building the company on a cash flow positive basis that will ensure Majik is positioned for the future laws to be developed. Majik is extremely frugal with its capital which enables Majik to execute on these new markets as they emerge through law reform.
Clinical Operations
Majik has successfully opened its Langley office and is currently seeing patients under the Special Access Program. Kelowna location has completed its demo and is beginning construction for an October open. With Majik operations soon to be 3 physical locations and online, Majik is the leader in delivering psychedelics to the population and providing help. In addition, Majik has partnered with a leading health focused metaverse company to deliver a psychedelic experience in the metaverse.
I thank you for your support and trust in navigating these markets to a profitable future. As a pharmacist and drug compounder, I still stay true that plant medicine is the future.
Kind regards,
Michael Forbes BSc. Pharm, MBA
Chief Executive Officer
Latest Presentation
Majik Minds provides guidance and comprehensive support to individuals pursuing psilocybin to improve their mental health.
Company Highlights
Breaking Down Walls
Majik Minds will be one of the first Canadian companies to be part of an ecological community with strategic partners, regulating access to psychedelics.
Education and Research
Academic and industry research shows mainstream society is becoming more curious and accepting.
Pioneering Safe Access to Psychedelics
Mental health is a $100B plus industry and current treatments are not evolving or changing at a pace we expected or needed.
Majik Minds Growth
Well funded by a team of entrepreneurs and medical experts with a well planned strategy for business expansion.
Investment Opportunity
Majik Minds will be positioned to cultivate, distribute and retail while we are waiting for the laws to open. Research shows there are many potential benefits from psychedelic treatment with most exciting research in treating mental health conditions such as depression and PTSD.